Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 30% ± 14% | |
goblet cell | 4 studies | 21% ± 4% | |
retinal bipolar neuron | 3 studies | 26% ± 5% | |
fibroblast | 3 studies | 21% ± 2% | |
basal cell | 3 studies | 29% ± 12% |
Insufficient scRNA-seq data for expression of ILVBL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 3083.22 | 180 / 180 | 100% | 44.11 | 430 / 430 |
pancreas | 100% | 2175.44 | 328 / 328 | 100% | 44.03 | 178 / 178 |
uterus | 100% | 2842.58 | 170 / 170 | 100% | 49.59 | 458 / 459 |
kidney | 100% | 4177.84 | 89 / 89 | 100% | 52.19 | 899 / 901 |
liver | 100% | 3234.64 | 226 / 226 | 100% | 46.38 | 405 / 406 |
thymus | 100% | 4879.58 | 653 / 653 | 100% | 61.44 | 603 / 605 |
skin | 100% | 4143.97 | 1809 / 1809 | 100% | 91.66 | 470 / 472 |
adrenal gland | 100% | 4777.68 | 258 / 258 | 100% | 67.87 | 229 / 230 |
esophagus | 100% | 3267.52 | 1445 / 1445 | 99% | 30.40 | 182 / 183 |
stomach | 100% | 3571.62 | 359 / 359 | 99% | 48.50 | 284 / 286 |
bladder | 100% | 3153.48 | 21 / 21 | 99% | 59.08 | 498 / 504 |
brain | 99% | 2110.55 | 2628 / 2642 | 99% | 44.66 | 700 / 705 |
intestine | 100% | 4830.13 | 966 / 966 | 99% | 60.21 | 520 / 527 |
prostate | 100% | 3040.57 | 245 / 245 | 98% | 31.25 | 494 / 502 |
breast | 100% | 3145.03 | 459 / 459 | 98% | 39.41 | 1095 / 1118 |
lung | 99% | 2259.22 | 575 / 578 | 98% | 34.55 | 1134 / 1155 |
adipose | 100% | 3104.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 220.87 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 26.61 | 29 / 29 |
spleen | 100% | 2054.97 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 43.00 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 96.20 | 1 / 1 |
blood vessel | 100% | 2157.80 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 4679.95 | 851 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 1112.74 | 746 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 54% | 796.00 | 502 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009099 | Biological process | valine biosynthetic process |
GO_0009097 | Biological process | isoleucine biosynthetic process |
GO_0001561 | Biological process | fatty acid alpha-oxidation |
GO_0016020 | Cellular component | membrane |
GO_0005948 | Cellular component | acetolactate synthase complex |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0030976 | Molecular function | thiamine pyrophosphate binding |
GO_0003984 | Molecular function | acetolactate synthase activity |
GO_0016829 | Molecular function | lyase activity |
GO_0005515 | Molecular function | protein binding |
GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
GO_0000287 | Molecular function | magnesium ion binding |
Gene name | ILVBL |
Protein name | IlvB acetolactate synthase like 2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein) 2-hydroxyacyl-CoA lyase 2 (Acetolactate synthase-like protein) (IlvB-like protein) |
Synonyms | AHAS HACL2 |
Description | FUNCTION: Endoplasmic reticulum 2-OH acyl-CoA lyase involved in the cleavage (C1 removal) reaction in the fatty acid alpha-oxydation in a thiamine pyrophosphate (TPP)-dependent manner. Involved in the phytosphingosine degradation pathway. . |
Accessions | M0R1B5 ENST00000527093.5 ENST00000534378.5 E9PL44 ENST00000600984.5 ENST00000598709.1 M0R026 A1L0T0 ENST00000533148.5 M0QZX5 ENST00000263383.8 ENST00000533747.1 E9PNL1 E9PJS0 |